Ignite Creation Date:
2024-05-06 @ 4:04 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04863001
Status:
UNKNOWN
Last Update Posted:
2021-05-06
First Post:
2021-04-14
Brief Title:
Use of Antiarrhythmic Drugs in Pediatrics
Sponsor:
Assiut University
Organization:
Assiut University
Study Overview
Official Title:
Adescriptive Study on the Use of Antiarrhythmic Drugs in Pediatrics Cardiology Unit Assiut University
Status:
UNKNOWN
Status Verified Date:
2021-04
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to describe the use of Cardiovascular Drugs in Pediatrics Cardiology unit Assiut University As regard
indications of use
proper dosage
proper management of side effects of their use
indications of use
proper dosage
proper management of side effects of their use
Detailed Description:
Arrhythmias occur in children and adolescents with congenital heart disease as well as those with structurally normal hearts Antiarrhythmic medications primarily affect the ion channels in cardiac myocytes that are responsible for generating currents that create the action potential
By altering the activity of these ion channels the action potential is changed in an attempt to reduce the likelihood of sustained arrhythmias There is awide range of antiarrhysmic drugs used in treatment Antiarrhysmics are therefore divided into five classes
Class I Antiarrhythmics that affect sodium channels slow depolarization Class II Drugs that counteract the sympathetic nervous system predominantly beta-blockers Class III drugs that affect the potasium channels prolong repolarization Class IV Drugs that affect calcium channels Calcium channel blockers Class V Vagotonic drugs Digoxin and other miscellaneous drugs
By altering the activity of these ion channels the action potential is changed in an attempt to reduce the likelihood of sustained arrhythmias There is awide range of antiarrhysmic drugs used in treatment Antiarrhysmics are therefore divided into five classes
Class I Antiarrhythmics that affect sodium channels slow depolarization Class II Drugs that counteract the sympathetic nervous system predominantly beta-blockers Class III drugs that affect the potasium channels prolong repolarization Class IV Drugs that affect calcium channels Calcium channel blockers Class V Vagotonic drugs Digoxin and other miscellaneous drugs
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None